RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
193 hedge funds and large institutions have $644M invested in Revance Therapeutics, Inc. in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 49 reducing their positions, and 32 closing their positions.
Holders
193
Holders Change
+7
Holders Change %
+3.76%
% of All Funds
2.83%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
74
Reduced
49
Closed
32
Calls
$18M
Puts
$5.27M
Net Calls
+$12.7M
Net Calls Change
+$9.27M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$15.5M |
| 2 |
2
CIBC Asset Management
Toronto,
Ontario, Canada
|
$10.1M |
| 3 |
3
Franklin Resources
San Mateo,
California
|
$41.7M |
| 4 |
4
BlackRock
New York
|
$65.5M |
| 5 |
5
Walleye Capital
New York
|
$8.16M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
226
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
227
Man Group
London,
United Kingdom
| – | – | – | – |
|
|
SO
228
STRS Ohio
Columbus,
Ohio
| $0 | 100 | – | – |
|
|
C
229
Covestor
London,
United Kingdom
| $0 | 11 | +5 | +83% |
|